Clinical Trial Update: A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, and immunogenicity of the V4020 vaccine in healthy volunteers. The trial targets Venezuelan Equine Encephalitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venezuelan Equine Encephalitis
• Venezuelan Equine Encephalitis Virus Infection

Drugs mentioned

• V4020 Vaccine (V4020)

Snippet

Sponsor: Medigen, Inc. | Conditions: Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Status: NOT_YET_RECRUITING